Can You Start and Stop Wegovy — and What Actually Happens When You Do?

Stopping Wegovy is not medically dangerous in itself, but weight often returns without ongoing treatment and lifestyle support.
Restarting after a break usually means going back to a lower dose and re-titrating, to manage side-effect risk, your prescriber sets the restarting dose.
A planned pause (for example, around surgery) should be discussed with your clinical team in advance, not managed alone.
Semaglutide leaves the body slowly over several weeks after the last dose, so effects do not cut off on day one of stopping.

Yes, you can start and stop Wegovy. There is no medical mechanism that makes stopping dangerous in itself, and some people do pause treatment for practical or clinical reasons. What matters is that any decision to stop, restart, or interrupt semaglutide is made with a prescriber rather than done unilaterally — because how you come off, and how you go back on, affects both your results and your safety. Wegovy (semaglutide) is a prescription-only medicine in the UK, so a clinician is involved at every stage by design.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Starting, pausing and restarting semaglutide: what the evidence and UK guidance actually say

The misconception worth clearing up first: stopping Wegovy is not a failure, but it does have consequences

Many people assume that once they are on Wegovy they are committed indefinitely, or, at the other extreme, that they can treat it like a course of antibiotics, take it until they hit a target weight and then stop cleanly. Neither picture is quite accurate.

Stopping semaglutide is not physically dangerous the way stopping certain heart or blood-pressure medicines can be. There is no withdrawal syndrome, no rebound spike in any measurable biomarker. What clinical trials do show clearly is that weight loss achieved on semaglutide is largely maintained only while the medicine is active. The STEP 1 extension study found that participants who stopped 2.4 mg semaglutide after 68 weeks regained on average about two-thirds of the weight they had lost within the following year. Appetite and the hormonal signals that drive it return towards their previous levels once the drug clears the body.

That is not a reason to avoid stopping. It is a reason to plan the stop (and any restart) with a prescriber who can think through the timing with you. You can read more about the specifics of what happens when you stop Wegovy in our dedicated guide.

The other thing worth knowing: semaglutide has a long half-life of roughly one week, so the medicine does not leave your system the day you skip your injection. Effects taper over several weeks. That matters both for expectations after stopping and for contraception planning, a point covered below.

Why people do stop Wegovy, and what a planned pause looks like

Clinically supervised reasons to pause Wegovy include planned surgery (anaesthetists need to know you are on a GLP-1 medicine, and NHS England guidance recommends discussing timing with your clinical team before any procedure), persistent severe side effects that are not settling, pregnancy or trying to conceive, or the practical reality that someone has reached a stable weight and wants to try maintaining it without medication.

In each case the right route is a conversation with your prescriber beforehand, not simply stopping the pen. If you are mid-titration (say, newly on 0.5 mg) a prescriber may suggest a specific point to pause rather than stopping mid-step. If you are on a maintenance dose and stopping for a short planned gap, knowing when you took your last injection matters for any restart plan.

For a practical overview of the titration schedule and what each dose step involves, the guide to starting Wegovy covers the full sequence in detail. And if you are thinking about stopping for a finite period and then going back on, the question of stopping and restarting Wegovy has its own dedicated page.

NHS guidance notes that semaglutide is not recommended during pregnancy, breastfeeding, or when trying to conceive. The MHRA advises using contraception throughout treatment and for a period afterwards; women who stop Wegovy to try for a pregnancy should discuss the wash-out period with their prescriber.

How restarting works (and why you usually go back to a lower dose

If you stop Wegovy and want to restart) whether that is after a two-week supply gap or a six-month break, the standard clinical approach is to re-titrate from a lower dose rather than picking up where you left off. The reason is straightforward: your tolerance to the gastrointestinal side effects of semaglutide resets during a break. Jumping straight back to 2.4 mg, or even 1.7 mg, after weeks off carries a meaningful risk of nausea and vomiting that re-titrating avoids.

How far back you start depends on the length of the gap and your prescriber's judgement. A very short interruption of a few days does not typically require restarting from scratch; a gap of several weeks usually does. Your prescriber will make that call based on your specific history. This is one of the reasons that ongoing clinical oversight matters for semaglutide, it is not a decision that should be made by reading a forum post at midnight.

The broader semaglutide information page covers the pharmacology behind why dose titration exists in the first place, which gives helpful context for anyone returning to treatment after a gap. For questions about starting at a specific dose, the page on whether you can begin semaglutide at 5 mg addresses that directly.

At nume, every repeat order goes through a fresh clinical review. That applies to restarts too, a named prescriber reads your updated information before any treatment is approved, which is the point at which the right restarting dose is confirmed. If you're thinking about returning to treatment, the sensible next step is a consultation rather than trying to work out the dose yourself. You can check your eligibility and speak to our prescribers at any stage. Our clinical team profile is at the link here if you want to know who reviews these decisions.

For people thinking about Wegovy for the first time rather than a restart, the Wegovy overview page and the weight-loss treatment guide are the clearest starting points. And if cost or access questions are on your mind, where to get Wegovy in the UK covers the practical picture honestly.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions